BSE India 150 Index

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informe3d that an inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen Pharmaceuticals Inc. (wholly owned subsidiary of the Company) located in Central Islip, Long Island, New York, USA, from 13th July, 2026 to 17th July, 2026 (EDT). The inspection was a routine current Good Manufacturing Practices (cGMP) Inspection. On conclusion of the inspection, the Company has received 1 inspectional observation in Form 483. The Company will work closely with the USFDA and is committed to address this comprehensively within stipulated time.

The above information is a part of company’s filings submitted to BSE. 

Pursuant to the provisions of Regulation 44(3) of the SEBI Listing Regulations, Tech Mahindra has informed that it enclosed the voting results and scrutinizer report (for remote e-voting and e-voting at the AGM) of the AGM of the Company held on Friday, 17th July, 2026 at 3:30 PM (IST) through video conferencing (VC)/other audio video means (OAVM). Ordinary Resolutions at Agenda Item Nos. 1 to 4 proposed in the Notice of the AGM are approved and passed with requisite majority by the Members of the Company. Ordinary Resolution at Agenda Item No. 5 pertaining to Shareholder’s notice on appointment of Krishnam Parasramka as a Director in terms of a notice received from a shareholder – Café Networks, under Section 160 of the Companies Act, 2013, is presently sub-judice. The Company has on 16 July 2026, received an ad-interim order dated 14 July 2026 passed by the learned Civil Court at Kolkata, in a case instituted by the proposing shareholder and the proposed director. The said order restrains the Company and certain other parties from giving effect to, or conducting any poll, including remote e-voting, or declaring the results of Item No. 5. Accordingly, in compliance with the said order and without prejudice to the Company’s rights and remedies in law, Item No. 5 was not taken up for voting or declaration at the AGM. The remaining items of business were transacted in accordance with the Notice of the AGM and approved by the Members with requisite majority. This intimation is also being uploaded on the Company’s website at www.techmahindra.com and on the website of National Securities Depository at www.evoting.nsdl.com.

The above information is a part of company’s filings submitted to BSE.